CLINICAL_TRIALS
trial_result
· 2017-05-08
Clinical Trial Update: A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma [Phase 2]
Summary
A Phase 2 study evaluating vismodegib in combination with surgery for previously untreated basal cell carcinoma was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Basal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-05-08